Factors Affecting International Normalized Ratio and Warfarin Individualized Dosing in Patients with Non-Valvular Atrial Fibrillation at Phanthong Hospital, Thailand
Natural and Life Sciences Communications · 12.05.2026 · 25 (4)
DOI: 10.12982/nlsc.2026.073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Natural and Life Sciences Communications, online erschienen am 12.05.2026. Verfasst von Watsit Chaipatiwat und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Warfarin, an oral anticoagulant, is widely used to prevent and treat thromboembolic events, including non-valvular atrial fibrillation (NVAF). According to its narrow therapeutic index, the international normalized ratio (INR) is used to monitor efficacy and safety. The INR outside the target range leads to bleeding or thromboembolic complications, establishing dose optimization of warfarin therapy as challenging. Determining the appropriate warfarin dose requires a comprehensive understanding of the factors influencing dose variability. This study aims to identify the factors affecting the INR and warfarin dosing. A cross-sectional study was conducted among all patients receiving warfarin therapy for NVAF, who were followed at Phanthong Hospital, Thailand. Descriptive statistics with regression were used to investigate the influence on the INR and warfarin dosing. All 104 patients, 61 (58.7%) females with a mean age of 73.6 years, were included in the study. The medians of weekly warfarin doses and the INR were 19.5 mg and 2.14, respectively. The weekly warfarin dose was the factor affecting the INR. For multiple analysis, only estimated glomerular filtration rate (eGFR) was significantly associated with the warfarin dosing provided to maintain within the therapeutic INR (P-value < 0.05). The predicted weekly warfarin dose could use the equation of: Dose in mg = (0.17 x eGFR) + (6.7 x INR) – 6.6. Although INR-based treatment of warfarin follows the Thai guideline, renal function-based warfarin dosing could help patients maintain within the therapeutic INR. Furthermore, this factor could be applied in a pharmacodynamic study to optimize time in the therapeutic range.
Zitieren
APA
Chaipatiwat, W., Tiamsati, P., Orakul, K., & Chaivichacharn, P. (2026). Factors Affecting International Normalized Ratio and Warfarin Individualized Dosing in Patients with Non-Valvular Atrial Fibrillation at Phanthong Hospital, Thailand. Natural and Life Sciences Communications, 25(4). https://doi.org/10.12982/nlsc.2026.073
Vancouver
Chaipatiwat W, Tiamsati P, Orakul K, Chaivichacharn P. Factors Affecting International Normalized Ratio and Warfarin Individualized Dosing in Patients with Non-Valvular Atrial Fibrillation at Phanthong Hospital, Thailand. Natural and Life Sciences Communications. 2026;25(4). doi:10.12982/nlsc.2026.073
BibTeX
@article{Chaipatiwat2026,
author = {Chaipatiwat, Watsit and Tiamsati, Pataranan and Orakul, Kantaphol and Chaivichacharn, Piyawat},
title = {Factors Affecting International Normalized Ratio and Warfarin Individualized Dosing in Patients with Non-Valvular Atrial Fibrillation at Phanthong Hospital, Thailand},
journal = {Natural and Life Sciences Communications},
year = {2026},
volume = {25},
number = {4},
doi = {10.12982/nlsc.2026.073}
}
EUVIMED